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ABSTRACT
The hypothalamus regulates numerous autonomic
responses and behaviors. The neuroactive substances corti-
cotropin-releasing factor (CRF), arginine-vasopressin (AVP),
histidine decarboxylase (HDC), melanin-concentrating hor-
mone (MCH), and orexin/hypocretins (ORX) produced in
the hypothalamus mediate a subset of these processes.
Although the expression patterns of these genes have been
well studied in rodents, less is known about them in
humans. We combined classical histological techniques
with in situ hybridization histochemistry to produce both 2D
and 3D images and to visually align and quantify expression
of the genes for these substances in nuclei of the human
hypothalamus. The hypothalamus was arbitrarily divided
into rostral, intermediate, and caudal regions. The rostral
region, containing the paraventricular nucleus (PVN), was
defined by discrete localization of CRF- and AVP-expressing
neurons, whereas distinct relationships between HDC,
MCH, and ORX mRNA-expressing neurons delineated spe-
cific levels within the intermediate and caudal regions.
Quantitative mRNA signal intensity measurements revealed
no significant differences in overall CRF or AVP expression
at any rostrocaudal level of the PVN. HDC mRNA expres-
sion was highest at the level of the premammillary area,
which included the dorsomedial and tuberomammillary
nuclei as well as the dorsolateral hypothalamic area. In
addition, the overall intensity of hybridization signal exhib-
ited by both MCH and ORX mRNA-expressing neurons
peaked in distinct intermediate and caudal hypothalamic
regions. These results suggest that human hypothalamic
neurons involved in the regulation of the HPA axis display
distinct neurochemical patterns that may encompass multi-
ple local nuclei. J. Comp. Neurol. 518:4591–4611, 2010.
VC 2010 Wiley-Liss, Inc.
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The hypothalamus mediates a diverse array of func-
tions and behaviors related to the endocrine system, cir-
cadian rhythms, and homeostatic drives. Studies of the
functional and anatomical relationships between hypo-
thalamic nuclei, which collectively produce no fewer than
20 different neuropeptides to regulate such processes
(Palkovits, 1984), have relied heavily on the use of
rodents. Evidence from rodents as well as human post-
mortem data indicates that several of these hypothalamic
signaling molecules regulate behaviors connected to
stress, feeding, and sleep (discussed below). Quantitative
studies examining possible links between disease and
locally synthesized neuroactive substances are currently
compromised by the lack of readily available comprehensive
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neurochemical maps of the human hypothalamus. In an
effort to overcome this problem, we generated an expres-
sion map of a number of clinically relevant signaling mole-
cules in the human hypothalamus. Two of these include
the anterior hypothalamic hormones corticotropin-releas-
ing factor (CRF; also termed corticotropin-releasing hor-
mone, CRH) and arginine-vasopressin (AVP). In both rats
and humans, each of these peptides is synthesized by dif-
ferent neurosecretory neurons within the paraventricular
nucleus (PVN) and those that generate AVP are found
within the supraoptic nucleus (SON) (Dierickx and Vande-
sande, 1977; Pelletier et al., 1983; Sawchenko et al.,
1984b; Koutcherov et al., 2000). Rodent studies suggest
that stimulated release of both neuropeptides enhances
the secretion of the pituitary secretagogue adrenocortico-
tropic hormone (ACTH) (Gillies et al., 1982; Rivier and Vale,
1983), which in turn stimulates the hypothalamo–pitui-
tary–adrenal (HPA) axis that is critical for stress responses
in both rodents and humans (Arborelius et al., 1999;
Swaab et al., 2005; Bao et al., 2008; Lightman, 2008).
More caudally located hypothalamic nuclei produce
other neuroactive substances to regulate HPA function
and additional physiological processes. Among these are
the histamine synthesizing neurons localized in the tuber-
omammillary region (TM) in rodents and humans (Castren
and Panula, 1990; Panula at al., 1990). In rodents, hista-
mine augments ACTH release (Kjaer et al., 1994), and
promotes food intake (Masaki et al., 2001) and arousal
(Huang et al., 2001). Neurons that produce melanin-con-
centrating hormone (MCH) and orexin/hypocretin (ORX)
are part of separate, but overlapping subpopulations par-
ticularly concentrated within the lateral hypothalamic
area (LHA) and dorsal hypothalamic area (DHA) in both
rats and humans (Qu et al., 1996; Broberger et al., 1998,
Elias et al., 1998). Rodent studies show that each of
these molecules increases ACTH release (Kuru et al.,
2000, Al-Barazanji et al., 2001, Kennedy et al., 2003) and
feeding behavior (Qu et al., 1996; Sakurai et al., 1998).
As determined by expression of the immediate-early gene
c-fos, MCH- and ORX-expressing neurons tend to be
more active during sleep (Verret et al., 2003) and wake
states (Estabrooke et al., 2001), respectively.
Examining the regulation of hypothalamic signaling
molecules is of particular interest given their relationship
to human neuropsychiatric and neurodegenerative disor-
ders. For instance, the brains of subjects who had been
diagnosed with depression display both an increased
number of immunoreactive CRF and AVP neurons and
increases in levels of the corresponding mRNAs (Raad-
sheer at al., 1994a; Purba et al., 1996; Meynen 2006).
Similarly, brains from Alzheimer’s disease patients show
elevated levels of CRF mRNA (Raadsheer et al., 1994a,
1995) along with degeneration of histaminergic neurons
(Airaksinen et al., 1991). In addition, a reduction in the
number of ORX-positive neurons is associated with narco-
lepsy (Peyron et al., 2000; Thannikal et al., 2000) and
Huntington’s disease (Aziz et al., 2008), while decreased
numbers of both ORX and MCH neurons are observed in
Parkinson’s disease (Thannikal et al., 2007). Taken to-
gether, these studies highlight the clinical importance of
understanding the pattern and regulation of gene expres-
sion in the human hypothalamus.
In the present study we aimed to expand on previously
published data by combining in situ hybridization histo-
chemistry (ISH) and classical histological staining to
delineate the anatomical patterns of gene expression for
CRF, AVP, the histamine-synthesizing enzyme histidine
decarboxylase (HDC), MCH, and ORX in the hypothala-
mus of healthy human subjects. To achieve this we first
determined the precise nuclear localization of mRNAs by
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signals in autoradiograms with adjacent 50-lm thick
Nissl-stained sections. Next, computer-based techniques
were used to generate both 2D and 3D reconstructions
from 10-lm thick sections illustrating the spatial relation-
ships between the neurons expressing the peptide
mRNAs. Using the thinner sections, quantitative analyses
were performed for each transcript within identical
regions of specimens from different brains in order to
determine the extent of neurochemical heterogeneity
within the human hypothalamus.
MATERIALS AND METHODS
Sample collection
Tissue was obtained from 53 brains at the University of
California, Irvine and Davis, Brain Repository. The Univer-
sity of California, Irvine Department of Psychiatry and
Human Behavior Psychological Autopsy Protocol, which is
based on procedures validated by Kelly and Mann (1996),
was used to assess each subject. Next-of-kin are asked
questions concerning decedents’ demographics, medical
history, medication use, hospitalizations, and manner of
death. Family members are also asked questions adapted
from the Structured Clinical Interview for the Diagnostic and
Statistical Manual for Mental Disorder, Fourth Edition (First
et al., 1995) in order to extract information concerning
decedents’ psychiatric symptoms and substance use. All
subjects selected for the current investigation were free of
any psychiatric disturbances at the time of death with no
known psychiatric disturbances over the life span, no
known prior treatment with psychotropic medications, and
no history of mental illness among first-order or second-
order relatives. All subjects exhibited no clinical evidence
of neurodegenerative disorders, such as Parkinson’s, Hun-
tington’s, dementia, or impairment as a result of cerebro-
vascular accident (CVA). All subjects had zero agonal fac-
tors and brain pH was above 6.5, which assures maximum
mRNA preservation (Li et al., 2004; Tomita et al., 2004)
(for detailed subject data see Table 1). Full details of the
psychological autopsy, medical history acquisition, matters
pertaining to agonal state, and other aspects related to tis-
sue quality and expression profiling were described previ-
ously (Li et al., 2004, 2007, Vawter et al., 2004; Atz et al.,
2007) and in other publications from our group. After re-
moval, brains were cooled to 4C, cut into coronal slices
0.8-cm thick, flash-frozen between two liquid nitrogen-
cooled aluminum plates, and stored at 85C as previ-
ously described (Jones et al., 1992).
ISH and histological methods using
50-lm thick sections
In brains from two subjects, the three or four frozen cor-
onal slices containing the diencephalon were identified and
a single block encompassing the hypothalamus and thala-
mus of both sides was removed from each slice with a me-
chanical saw. The temperature of the blocks was raised to
4C, at which point they were fixed in cold 4%
TABLE 1.
Subject Demographics and Postmortem Data
Subject ID Gender Age Cause of death AFS pH PMI Race
1 Male 49 Cardiac event 0 6.68 27.5 C
2 Male 40 Chronic glomerulonephritis 0 6.76 12.3 C
3 Male 39 Electrocution 0 7.02 30 C
4 Male 56 Cardiac event 0 6.98 24.5 C
5 Male 66 Cardiac event 0 6.94 18 C
6 Male 30 Cardiac event 0 7.15 18.2 C
7 Male 48 Cardiac event 0 6.79 20.2 C
8 Male 65 Hemorrhagic epicarditis 0 6.88 13.5 AA
9 Male 55 Cardiac event 0 6.89 15 C
10 Male 41 Cardiac event 0 7.01 22.5 C
11 Male 52 Cardiac event 0 6.53 18.8 C
12 Male 58 Cardiac event 0 6.58 21 C
13 Male 29 Cardiac event 0 6.81 18.2 PI
14 Male 64 Cardiac event 0 7.13 10.5 C
15 Female 45 Trauma 0 7.05 16 C
16 Female 74 Respiratory failure 0 7.21 18.5 C
17 Female 73 Cardiac event 0 7.21 20 C
18 Male 75 Cardiac event 0 7.18 19 C
19 Male 67 Cardiac event 0 6.96 15 C
20 Male 51 Cardiac event 0 N/A 19 C
21 Male 62 Cardiac event 0 N/A 17.8 C
The table shows the serial numbers, general demographics, cause of death, pH, agonal factors scores, and postmortem interval for the 21 subjects
used in the study.
Abbreviations: AA, African American; AFS, agonal factors score; C, Caucasian; N/A, not available; PI, Pacific Islander; PMI, postmortem interval.
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paraformaldehyde in 0.1 M phosphate buffer (PB; pH 7.4)
overnight, then infiltrated with 30% sucrose in 0.1 M PB,
refrozen in dry ice, and kept at 85C until sectioning. The
blocks were assembled in rostrocaudal order and serial
sections 50-lm thick were cut from each on a sliding
microtome. They were collected in groups of 10: eight in
4% paraformaldehyde in 0.1 M PB, in which they remained
for 7 days prior to ISH, and two in 0.1 M PB for Nissl
staining.
For ISH, sections were washed in 0.1 M glycine in 0.1 M
PB (pH 7.4) followed by two washes in 0.1 M PB (pH 7.4)
and two washes in 2 saline sodium citrate (SSC; 1 SSC
is 0.15 M sodium chloride and 0.015 M sodium citrate, pH
7.0). Sections were then incubated in hybridization solution
containing 50% formamide, dextran sulfate 10%, 0.7% Ficoll,
0.7% polyvinyl pyrolidone, 0.5 mg/mL yeast tRNA, 0.33
mg/mL yeast tRNA, 0.33 mg/mL denatured herring sperm
DNA, 20 mM dithiothreitol (DTT), and 5.0 105 cpm/mL of
the 33P-labeled antisense or sense probe. The target, size,
and accession number of each cRNA probe were as follows:
CRF, 586 nucleotides (nt), 216–802 nt of NM 000756; AVP,
145 nt, 473–618 nt of NM 000490; HDC, 850 nt, 1235–
2085 nt of NM 002112; MCH, 388 nt, 10–398 of NM
002674; ORX, 327 nt, 3–330 of NM 001524. Hybridization
was carried out overnight at 60C in a humid chamber. Af-
ter hybridization, sections were washed twice in 4 SSC at
60C, digested with 20 lg/mL of ribonuclease A (pH 8.0)
for 30 minutes at 45C, and washed through descending
concentrations of SSC to a final stringency of 0.5 SSC.
Sections were mounted on gelatin-coated slides, dried, and
exposed to Amersham b-max autoradiographic film for 3 or
7 days, after which they were developed in Kodak GBX
developer (Eastman Kodak, Rochester, NY). Sections for
Nissl staining were mounted on glass slides, dried, stained
with thionin, dehydrated, cleared, and coverslipped in DPX
mountant (VWR International, Poole, UK). Higher-magnifica-
tion images of the original Nissl-stained sections can be
found in Supporting Figures 1A through 11A.
ISH and histology methods using 10-lm
thick sections
Blocks containing the hypothalamus were removed from
the frozen slices of the remaining 51 brains. They were sec-
tioned on a cryostat at 10 lm, thaw-mounted onto Super-
frost/Plus glass slides (Fisher Scientific, Pittsburgh, PA),
and stored at 80C until use. For a detailed description
of this in situ hybridization protocol, see Kabbaj et al.
(2000). Mounted sections at 500-lm intervals were immer-
sion-fixed in 4% paraformaldehyde for 1 hour, washed in
2 SCC, and incubated for 10 minutes in 0.1 M triethanol-
amine (TEA). Slides were subsequently rinsed in distilled
water, the sections dehydrated in ascending alcohol con-
centrations, air-dried, and hybridized with 35S-labeled
cRNA probes at 55C overnight. The target, size, and
accession number of each cRNA probe were identical to
those used for processing 50-lm sections (see above).
Slides were subsequently rinsed in 2 SSC, digested with
ribonuclease A (200 lg/mL), washed in descending SSC
concentrations, dehydrated, and exposed to Kodak Biomax
MR film. Exposure times were as follows: CRF, 7 days; AVP,
24 hours; HDC, 6 days; MCH, 6 days; ORX, 5 days.
Sections adjacent to those processed for ISH were
stained using a combination of Luxol Fast Blue and Cresyl
Violet. Slides were immersed in a solution containing
0.94% Luxol Fast Blue (w/v), 89.6% ethanol (v/v) and 0.5%
acetic acid (v/v), and then incubated overnight at 37C.
The slides were then washed sequentially in 95% ethanol,
distilled water, 50% lithium carbonate, 70% ethanol, dis-
tilled water, 70% ethanol, and then placed in 1% Eosin Y so-
lution for 1 minute. The slides were then rinsed in distilled
water, dipped in 1% Cresyl Violet, rinsed in tap water, dehy-
drated, cleared in xylene, and coverslipped with Permount.
Image Capture and Quantification
The autoradiograms of each in situ-labeled 50-lm sec-
tion and the matching Nissl-stained section were imaged
at 5,000 d.p.i with a Phase One (Phase One A/S, Freder-
icksberg, Denmark) 400  500 digital camera mounted on a
Nikon Multiphot photomacrographic apparatus. Captured
images were exported to Adobe Photoshop CS 8.0 (Adobe
Systems, San Jose, CA), downsized to 1,200 d.p.i.,
assembled in rostrocaudal order, and images of autoradio-
graphs at the same rostrocaudal levels matched to those
of the corresponding Nissl-stained sections and matched
for brightness and contrast. Nuclei of the hypothalamus
and adjacent regions were identified primarily in terms of
the atlases of Saper (2004) and Jones (2007) and labeled
accordingly. Autoradiograms of sections hybridized with
sense probes displayed light background staining only.
ISH films developed from 10-lm thick sections and ad-
jacent Fast Blue/Cresyl Violet slides were digitized at
1,600 pixels/inch using a flat bed scanner (Microtek
ScanMaker 1000XL, Microtek, Carson, CA) and Nikon LS
4000 (Nikon, Tokyo, Japan) slide scanner, respectively.
Specific hypothalamic nuclei and areas within nuclei were
outlined using the freehand tool in ImageJ software (NIH,
Bethesda, MD). Specific nuclei were identified by the
combined analyses of ISH and Nissl staining on the 50-
lm sections from the two brains prepared in this way.
The optical density of hybridization signal within the out-
lined nuclei was defined as follows: Signal intensity of
CRF, AVP, HDC, MCH, and ORX gene expression was
quantified in a linear grayscale range and values gener-
ated utilizing ImageJ were expressed as optical density
units. It should be noted that these values are dependent
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on density of labeled cells within an analyzed region and
are, therefore, not comparable across probes. For each
cRNA probe, only optical density measurements of at
least 3.5 the standard deviation (3.5 STD) above the
mean of nonspecific signals in each section were col-
lected. Resulting data was analyzed using GraphPad Soft-
ware (GraphPad Software, La Jolla, CA) to perform one-
way analyses of variance (ANOVAs) and subsequent
Tukey post-test when appropriate. Effects were consid-
ered significant at P < 0.05.
Anatomical alignment of hybridization
signals in 10-lm thick sections
Because of discrepancies resulting from incomplete-
ness of the blocks and irregularities in the angle of
Figure 1. Nissl-staining and ISH in adjacent 50-lm thick sections from the anterior PVN region. Photomicrographs of a Nissl-stained sec-
tion (A) and autoradiograms of adjacent sections labeled with cRNA probes for CRF (B), AVP (C), HDC (D), MCH (E), and ORX (F). Note
the weak CRF ISH signal in the SON and absence of HDC, MCH, and ORX expression at this anatomical level. AC, anterior commissure;
AHA, anterior hypothalamic area; F, fornix; IC: internal capsule; NST: nucleus of stria terminalis; OCX, optic chiasm; PVN, paraventricular
nucleus; SI: substantia innominata; SON, supraoptic nucleus. Scale bar ¼ 1 mm.
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sectioning, not all blocks from the 51 brains could be
used for mapping the full extent of the relevant hypothala-
mic nuclei. Blocks from 19 of the brains sectioned at
10 lm showed no loss of tissue from the hypothalamus
and the sections were oriented in planes that facilitated
reconstruction. These were used for 2D and 3D recon-
structions. Using Adobe Photoshop CS 8.0, Luxol Fast
Blue images were converted to grayscale while in situ
hybridization images were first inverted in grayscale and
then converted to RGB for artificial color coding of each
probe (CRF-red, AVP-green, HDC-purple, MCH-cyan, ORX-
yellow). Using the Adobe Photoshop CS 8.0 layer menu,
2D representations were constructed. In these, captured
images of Luxol Fast Blue þ Cresyl Violet-stained sec-
tions formed the background at reduced opacity to an
overlaid image of an adjacent section labeled by in situ
Figure 2. Nissl-staining and ISH in adjacent 50-lm thick sections from the intermediate PVN region. Photomicrographs of a Nissl-stained sec-
tion (A) and autoradiograms of adjacent sections demonstrating expression of CRF (B), AVP (C), HDC (D), MCH (E), and ORX (F). Note the
expression of AVP, but not CRF, in the LHA. AL: ansa lentyicularis; DHA, dorsal hypothalamic area; DM, dorsomedial hypothalamic nucleus; F,
fornix; GPi: internal; segment of globus pallidus; IC: internal capsule; INF, infundibulum; LHA, lateral hypothalamic area; OT, optic tract; PVN,
paraventricular nucleus; SM: stria medullaris; SON, supraoptic nucleus; VM, ventromedial hypothalamic nucleus. Scale bar ¼ 1 mm.
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hybridization. Merged 2D images were then compared
with those from descriptions of the human hypothalamus
(Braak and Braak, 1987, 1992; Airaksinen et al., 1991;
Elias et al., 1998; Trottier et al., 2002; Saper, 2004) to
generate a neurochemical atlas of each hypothalamus.
For constructing 3D representations of gene transcrip-
tion patterns, grayscale ISH TIFF files for each transcript
were overlaid and digitally cleaned to eliminate artifacts
using Adobe Photoshop CS 8.0. The resulting files were
then exported to Volocity 5.1 (Perkin Elmer, Waltham,
Figure 3. Nissl-staining and ISH in adjacent 50-lm thick sections from the caudal PVN region. Photomicrographs of a Nissl-stained sec-
tion (A) and autoradiograms of adjacent sections demonstrating expression of CRF (B), AVP (C), HDC (D), MCH (E), and ORX (F). DHA,
dorsal hypothalamic area; DM, dorsomedial hypothalamic nucleus; F, fornix; IC: internal capsule; INF, infundibulum; LHA, lateral hypothala-
mic area; OT, optic tract; PVN, paraventricular nucleus; R: reticular nucleus of thalamus; SM: stria medullaris; SON, supraoptic nucleus;
TM, tuberomammillary nucleus; TU, tuberal region; VM, ventromedial hypothalamic nucleus. Scale bar ¼ 1 mm.
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Figure 4. 2D reconstruction of the human hypothalamus in the region of the paraventricular nucleus. Overlays of ISH signals over the
grayscale images of an adjacent Nissl-stained section at different levels of the anterior hypothalamus. A–C: Sequential rostrocaudal order
which can be determined by the pattern of gene expression in relation to the fornix. AHA, anterior hypothalamic area; dlSON, dorsolateral
supraoptic nucleus; DM, dorsomedial hypothalamic nucleus; F, fornix; LHA, lateral hypothalamic nucleus; PVN, paraventricular nucleus;
SON, supraoptic nucleus; vmSON, ventromedial supraoptic nucleus; VM, ventromedial hypothalamic nucleus.
Figure 5. 3D reconstruction and rotation of the human hypothalamus in the region of the paraventricular nucleus. Combined visualization
of CRF, AVP, HDC, MCH, and ORX. The representative 3D shows a 0 front view (A–E) as well as a 45 z–axis visualization (F–J) and 180
caudal view (K-O). 3V, third ventricle; F, fornix; PVN, paraventricular nucleus; SON, supraoptic nucleus.
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MA) where the following data were entered: distance
between images on the Z plane (500 lm), number of
color channels desired (one per transcript), and number
of Z slices per volume, which was set as an automated
function. The program then converted the 2D pixels into
3D voxels that rendered a representation of the spatial
distribution of the gene expression pattern.
RESULTS
CRF and AVP mRNA distribution
For the purposes of description, the hypothalamus was
arbitrarily divided into three rostrocaudal regions. The
most anterior region was defined as that containing the
full rostrocaudal extent of the PVN. The intermediate
region was defined as that containing the greater part of
the ventral medial nucleus and adjacent tuberal area. The
caudal region was that which contained the full extent of
the mammillary nuclei. Within each region, sublevels
could also be discerned based on the presence of particu-
lar nuclei and the expression patterns of individual
mRNAs. Evaluation of saturated ISH signals and adjacent
50-lm Nissl-stained sections revealed a similar distribu-
tion of both CRF and AVP mRNA in cells forming the PVN
and SON. In the PVN the localization of both molecules
was coextensive, beginning rostrally where labeled cells
were located ventral to the fornix and adjacent to the 3V
(Fig. 1B,C) and continued with the localization shifting
medial (Fig. 2B,C), and finally dorsal to the fornix (Fig.
3B,C). A change in the topography of CRF and AVP
mRNA-expressing cells also followed the changes in topo-
graphic localization of the SON. The presence of weak
CRF ISH signal in the SON contrasts with the results of
Mouri et al. (1992), who reported an absence of CRF im-
munoreactivity in the SON of the human hypothalamus,
but is in agreement with similar studies in rodents that
detected specific CRF signal in the SON (Burlet et al.,
1983; Shioda et al., 1985). Hybridization signals for both
probes displayed a clear rostrocaudal transition from a
single neuronal group along the optic tract rostrally (Fig.
1B,C) to distinct dorsolateral (dlSON) and ventromedial
(vmSON) segments separated by the lateral hypothalamic
area (LHA) including its larger celled lateral part more
posteriorly (Fig. 2B,C). At the latter level, unlike CRF,
appreciable AVP expression was also observed within the
LHA and dorsal hypothalamic area (DHA) (Fig. 2B). This
labeling may reflect expression in neurons displaced from
the SON.
To further visualize hypothalamic neurochemical archi-
tecture and to perform quantitative measurements, ISH
experiments utilizing 10-lm thick sections from 19 of the
51 brains were used, for reasons outlined in Materials
and Methods. Of these, a total of 11 exhibited CRF and
AVP mRNA signal in the PVN. Computer-based 2D color-
coded photomicrographs (Fig. 4A–C) showed that CRF
and AVP ISH signals largely overlap along the rostral-cau-
dal extent of the PVN. However, CRF expression did
appear slightly more intense medially adjoining the 3V,
where consistent overlap with AVP mRNA was not evident
(Fig. 4A,B). 3D reconstruction of the PVN region and rota-
tion of 0 (Fig. 5A–E), 45 (Fig. 5F–J), and 180 (Fig. 5K–
O) demonstrates the continuity of CRF mRNA within the
PVN as well as AVP mRNA in the PVN and SON. More-
over, 3D visualization of the PVN showed the spatial dis-
tribution of CRF and AVP mRNAs along the z-axis, defined
by depth, as well as by its relationship to HDC, MCH, and
ORX mRNA transcript expression, which began at the
level of the intermediate and caudal PVN (see below).
Quantitative analyses between subjects along the rostro-
caudal extent of the PVN showed no significant differen-
ces in the overall intensity of CRF or AVP mRNA between
rostral, intermediate, or caudal levels of the hypothala-
mus (Fig. 6A,B). Due to the disparities in the dorsoventral
and/or mediolateral extent of some of the hypothalamic
blocks, insufficient samples of the SON were available for
Figure 6. Quantitative in situ hybridization of three subregions of
the human PVN. The suggested divisions are based in a combina-
tion of anatomical features and signal topography for each tran-
script. Regions 1, 2, and 3 correspond to the rostral,
intermediate, and caudal PVN, respectively. A: Quantitation of
AVP signal intensity. B: Quantitation of CRF signal intensity.
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subregional quantitative analyses. In contrast to 50-lm
sections, CRF mRNA was rarely detected in the SON in
10-lm hypothalamic sections. This observation likely
reflects the inability to identify low expression levels in
thin sections of the human SON.
HDC, MCH, and ORX mRNA distribution
Comparisons between ISH and Nissl-stained 50-lm
guide sections revealed HDC, MCH, and ORX mRNA label-
ing at the levels of the intermediate and caudal PVN,
where each exhibited similar gene expression patterns.
Figure 7. Nissl-staining and ISH in adjacent 50-lm thick sections from the intermediate region of the hypothalamus. Photomicrographs of
a Nissl-stained section (A) and autoradiograms of adjacent sections demonstrating expression of HDC (B), MCH (C), and ORX (D). DHA,
dorsal hypothalamic area; DM, dorsomedial hypothalamic nucleus; F, fornix; IC: internal capsule; LHA, lateral hypothalamic area; OT, optic
tract; PVN, paraventricular nucleus; R: reticular nucleus of thalamus; SON, supraoptic nucleus; TM, tuberomammillary nucleus; Tu: tuberal
region; VM: ventromedial hypothalamic nucleus. Scale bar ¼ 1 mm.
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(see Figs. 4B,C and 5A–C for 2D and 3D visualizations,
respectively). At the intermediate PVN level, mRNA for
each of these signaling molecules was largely confined to
the LHA with ORX additionally localized to the ventrome-
dial hypothalamic nucleus (VM) (Fig. 2D–F). At the level
of the caudal PVN, all three hybridization signals
extended into the lateral aspect of the LHA (Fig. 3D–F).
However, in contrast, MCH and ORX mRNA were also
jointly expressed in the DHA and DM (Fig. 3E,F).
In intermediate and caudal regions of the hypothala-
mus, five distinct successive levels could be distinguished
by differences in the labeling pattern. Beginning at a level
where the PVN ends and the tuberomammillary nucleus
(TM) becomes evident, HDC, MCH, and ORX mRNA each
Figure 8. Nissl-staining and ISH in adjacent 50-lm thick sections from the intermediate region of the hypothalamus (plane of the lateral
tuberal nucleus). Photomicrographs of a Nissl-stained section (A) and autoradiograms of sections demonstrating expression of HDC (B),
MCH (C), and ORX (D). DHA, dorsal hypothalamic area; DM, dorsomedial hypothalamic nucleus; F, fornix; IC: internal capsule; INF, infun-
dibulum; LTul, lateral portions of the lateral tuberal nucleus; LTum, medial portion of the lateral tuberal nucleus; LHA, lateral hypothalamic
area; OT, optic tract; PVN, paraventricular nucleus; R: reticular nucleus of thalamus; SON, supraoptic nucleus; TM, tuberomammillary nu-
cleus; TU, tuberal region; VM, ventromedial hypothalamic nucleus. Scale bar ¼ 1 mm.
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displayed characteristic expression patterns. HDC hybrid-
ization signal was robust throughout most of the ventral
hypothalamus including the HLA, TM, and DM (Fig. 7B).
HDC mRNA-expressing cells generally circumscribed the
VM with sparse expression centrally. This expression pat-
tern appears to correspond to the TM subdivisions previ-
ously described by Panula et al. (1990), with HDC neu-
rons extending into what we define as the DM and the
HLA. These likely represent displaced HDC cells corre-
sponding to the medial and lateral TM, respectively, while
a combination of the HLA and TM represent the ventral
TM segment. Nonetheless, MCH mRNA shared some
degree of similarity with both HDC by displaying substan-
tial signal in the HLA, DM, and DHA (Fig. 7C). ORX mRNA
expression was generally confined to the DHA (Fig. 7D).
Moving caudally, the lateral (LTul) and medial (LTum)
segments of the lateral tuberal nucleus become apparent
within the LHA region. Here, HDC, MCH, and ORX hybrid-
ization signal was similar to that found at the previous
level. However, the LTul and LTum were virtually void of
HDC and MCH signal (Fig. 8B–D). In the caudal region of
the hypothalamus the presence of the mammillary
peduncle and its transition into the mammillothalamic
tract serve as key anatomical landmarks. Where the
mammillary peduncle is present ventral to the fornix and
the rostral parts of the mammillary bodies begin to take
shape, HDC mRNA is still confined to cells of the DM, TM,
and HLA (Fig. 9B). At this level the cells showing the pres-
ence of HDC signal in the latter two nuclei correspond to
the caudal TM segment previously described by Panula
et al. (1990). The extent of MCH mRNA expression was
shown to span the LHA, DM, and DHA (Fig. 9C), while
ORX mRNA was localized to cells of the DHA (Fig. 9D).
Within the dorsal part of the DHA and close to the midline
within an area of dense MCH positive neurons, the la-
beled neurons formed a ring-like shape outlining a central
Figure 9. Nissl-staining and ISH in adjacent 50-lm thick sections from the caudal hypothalamic region (plane of rostral mammillary
bodies). Photomicrographs of a Nissl-stained section (A) and autoradiograms of sections demonstrating expression of HDC (B), MCH (C),
and ORX (D). DHA, dorsal hypothalamic area; DM, dorsomedial hypothalamic nucleus; F, fornix; IC: internal capsule; LHA: lateral hypothala-
mic area; MM, medial mammillary nucleus; MP, mammillary peduncle; OT, optic tract; TF: thalamic fasciculus; TM, tuberomammillary nu-
cleus. Scale bar ¼ 1 mm.
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core of nonlabeled cells. Previous double-labeling ISH
experiments (Krolewski et al., 2008) in combination with
examination of adjacent Nissl-sections demonstrated
that the center portion exhibiting an absence of signal is
not a white matter tract, but rather a separate neuro-
chemically distinct neuronal cluster.
More caudally, there is appreciable enlargement of the
mammillary bodies and the formation of the mammillo-
thalamic tract, which demarcates the posterior hypo-
thalamic area (PHA). Here, diminishing size of the mam-
millary bodies and a shift of the PHA toward the 3V are
characteristic. Among the most caudal regions, with the
exception of visible HDC expression within the cells of
the lateral mammillary nucleus (ML) (Fig. 10B), the com-
parative relationships between HDC, MCH, and ORX
mRNA-expressing cells are generally similar, with a no-
ticeable qualitative reduction in the area of expression
caudally (Figs. 10A–D and 11A–D).
In an effort to further detail the relative distributions of
HDC, MCH, and ORX expression and determine potential
quantitative regional differences, we studied in detail sec-
tions from hypothalamic blocks of the 19 brains that had
intact hypothalami, showed optimal orientation, and exhib-
ited hybridization. The spatial distribution of cells express-
ing HDC, MCH, and ORX mRNA demonstrated distinct non-
overlapping regions that could be recognized based on
characteristics such as shape and intensity of labeling of
the regions containing labeled cells. The anatomical rela-
tionships between nuclei expressing these transcripts are
represented by 2D color-coded photomicrographs (Fig.
Figure 10. Nissl-staining and ISH in adjacent 50-lm thick sections from the caudal hypothalamic region (plane of the intermediate mam-
millary bodies). Photomicrographs of a Nissl-stained section (A) and autoradiograms of adjacent sections demonstrating expression of
HDC (B), MCH (C), and ORX (D). CP: cerebral peduncle; F, fornix; LHA: lateral hypothalamic area; ML, lateral mammillary nucleus; MM,
medial mammillary nucleus; MT, mammillothalamic tract; OT: optic tract; PHA, posterior hypothalamic area; Sb: subthalamic nucleus; TF:
thalamic fasciculus. Scale bar ¼ 1 mm.
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12A–D) and 3D reconstructions (Fig. 13A–L). Sections
from hypothalami of the 19 subjects with suitable anatomi-
cal orientation were aligned by matching the outlines of
nuclei from section to section (HDC, n ¼ 11; MCH, n ¼ 6,
ORX, n ¼ 7). The overall intensity of hybridization signal
within specific hypothalamic nuclei was quantified in a lin-
ear grayscale range and expressed as optical density
units.
Examination of five comparable regions displaying HDC
mRNA expression was undertaken. Starting at the level of
the caudal PVN, where the rostral LHA is situated, a pro-
gressive increase in the intensity of HDC mRNA signal
leading up to the level of the TM, caudal DM and more
caudal LHA was revealed (Fig. 14A). Individual signal in-
tensity measurements taken from the TMm, TMv, TMl,
and TMc as described by Panula et al. (1990) showed no
subregional differences. However, when measuring com-
bined nuclear signal intensity, the planes of the premam-
millary area and rostral mammillary bodies showed the
highest densitometric expression of HDC mRNA.
Figure 11. Nissl-staining and ISH in adjacent 50-lm thick sections from the caudal hypothalamic region (plane of the caudal mammillary
bodies). Photomicrographs of a Nissl-stained section (A) and autoradiograms of adjacent sections demonstrating expression of HDC
(B), MCH (C), and ORX (D). CP: cerebral peduncle; F, fornix; LHA: lateral hypothalamic area; MM, medial mammillary nucleus; MP: mammil-
lary peduncle; MT, mammillothalamic tract; PHA, posterior hypothalamic area; Sb: subthalamic nucleus; TF: thalamic fasciculus. Scale bar
¼ 1 mm.
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Similar to HDC patterns of expression, MCH and ORX
patterns each initially appeared as low-intensity signal
that progressively became more intense along the rostro-
caudal axis and declined after achieving maximum inten-
sity. In the caudal region of the hypothalamus, in identify-
ing the hypothalamic nuclei containing highest
expression levels, we evaluated MCH and ORX expression
intensity within three and four planes, respectively, that
encompassed the overall region of labeled cells. Mea-
surement of MCH hybridization signal was evaluated in
the DHA and PHA only and was significantly different and
most intense in the DHA at the level of the rostral mam-
millary bodies, which included the characteristic ring-like
configuration of labeled cells (Fig. 14B). The measure-
ments acquired from the most rostral plane analyzed for
ORX mRNA showed expression in the DM nucleus; those
at more caudal planes showed labeling confined to the
DHA. Quantitative analysis demonstrated ORX hybridiza-
tion signal to be highest in the DHA at a level dorsal to
the premammillary area (Fig. 14C).
DISCUSSION
Importance of human hypothalamic
biochemical maps
In the present study we utilized ISH histochemistry in
order to generate gene expression maps for CRF, AVP,
HDC, MCH, and ORX in the human hypothalamus. These
anatomical templates serve not only to map specific
nuclei, but also to create maps of the nuclear relation-
ships characterized by labeling with selected probe sets.
Establishing these types of neurochemical maps will form
a baseline for further studies and facilitate the identifica-
tion of nuclei expressing particular mRNAs in the human
hypothalamus. The importance of understanding the neu-
rochemical organization of the human hypothalamus is
highlighted by the dysregulation of one or more of these
neuroactive substances in neuropsychiatric disorders
such as depression (Raadsheer et al., 1994a, 1995;
Pruba et al., 1996; Meynen 2006; Wang et al., 2008), Alz-
heimer’s disease (Airaksinen et al., 1991; Raadsheer
et al., 1995), Huntington’s disease (Aziz et al., 2007), Par-
kinson’s disease (Thannikal et al., 2007), and narcolepsy
(Peyron et al., 2000; Thannikal et al., 2000).
Experimental evidence suggests that the genes whose
expression was studied function, in part, to coordinate bi-
ological events throughout the HPA axis, which implies
potential overlapping roles in neuropsychiatric/neuro-
logic disorders. This is of particular importance given that
the HPA axis exerts influence over an array of homeo-
static and autonomic events that are central to an organ-
ism’s ability to respond and adapt to environmental chal-
lenges. The role of CRF- and AVP-expressing neurons
within the PVN, which has been greatly detailed in
depression, are crucial to such mechanisms and, there-
fore, human health and disease (for reviews, see: Saw-
chenko et al., 1996; Herman et al., 2003; McEwen,
2007). Along with studies showing increased expression
of these genes in depression (Raadsheer et al., 1994a,
1995; Pruba et al., 1996; Meynen 2006; Wang et al.,
2008), heightened levels of cerebrospinal fluid-derived
CRF-like immunoreactivity (Nemeroff et al., 1984), as well
as alterations in cortical CRF receptor expression (Merali
et al., 2004), have also been demonstrated. These find-
ings not only validate the need to pharmacologically tar-
get CRF and AVP receptors in the treatment of depressive
Figure 12. Overlays of ISH signals over the grayscale images of adjacent Cresyl Violet / Luxol Fast Blue-stained sections at different lev-
els of the intermediate and caudal regions of the human hypothalamus. A: Premammillary level. B: Level of the caudal end of the fornix.
C: Rostral mammillary level at the principal mammillary fasciculus. D: Posterior level through the medial mammillary nucleus. F, fornix; Ff,
field of Forel; MM, medial mammillary nucleus; MP, peduncle; Mt, mammillothalamic tract; TMc, caudal tuberomammillary nucleus; TMl;
lateral tuberomammillary nucleus; TMm, medial tuberomammillary nucleus; TMv, ventral tuberomammillary nucleus.
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symptoms, as done previously (Holsboer et al., 2003a,b),
but to further uncover additional neurochemical signaling
molecules that mediate the HPA axis.
Rodent studies indicate that central administration of
histamine, MCH, or ORX enhances circulating levels of
ACTH (Kjaer et al., 1994; Kuru et al., 2000; Al-Baranzanji
et al., 2001; Kennedy et al., 2003). Similar studies also
demonstrate that histamine and ORX each function to
elevate CRF and AVP mRNA in the PVN (Kjaer et al.,
1994; Al-Baranzanji et al., 2001). Although the fact that
MCH infused directly into the PVN enhances ACTH
release (Kennedy et al., 2003) suggests a direct mecha-
nism, this neuropeptide along with histamine and ORX
may also modulate HPA-related processes through poly-
synaptic mechanisms. Histaminergic, MCH, and ORX neu-
rons transmit information via extensive projections
throughout the brain, to regions that include the thala-
mus, hippocampus, amygdala, dorsal raphe, locus coeru-
leus, and nearly the entire cortical mantle (Haas and Pan-
ula, 2003; Adamantidis and de Lecea, 2008). Taken
together, the ability of these signaling molecules to
increase ACTH secretion, and thus stimulate the HPA
axis, implies a cooperative system that should be consid-
ered when examining human CNS disorders linked to
Figure 13. 3D reconstruction of in situ hybridization signals for HDC (purple), MCH (blue), and orexin (yellow) mRNA. Solid drawings of
the fornix (F) and medial mammillary nucleus (MM) were added for anatomical reference. This set of images represents rotation from the
0 front (A–D), to the 90 sagittal (E–H), and 180 caudal (I–L) views. Note the considerable overlap between the transcripts is accompa-
nied by the predominance for each within specific areas. F: fornix. MM: mammillary bodies.
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stress (Swaab et al., 2005; Bao et al., 2008). Examination
of this human hypothalamic network requires precise an-
atomical localization, as recently demonstrated through
the use of laser capture microdissection (LCM) and quan-
titative PCR of the PVN (Wang et al., 2008). In the PVN of
brains from depressed subjects, levels of mRNA for CRF
are increased along with those for CRFR1, AVPR1A, min-
eralocorticoid, and estrogen receptors which mediate
CRF production (Wang et al., 2008).
CRF and AVP maps
Quantification of both CRF and AVP transcript signals
in our sections showed no significant differences in the
overall signal intensity of either transcript along the ros-
trocaudal axis of the PVN. However, the qualitative
results of the current ISH-driven 2D and 3D reconstruc-
tions of the human PVN revealed an unexpectedly strong
anatomical overlap between CRF and AVP mRNA expres-
sion along the rostrocaudal axis of the nucleus. This is
somewhat different from the pattern described in the rat
by Simmons and Swanson (2008) in their high-resolution,
serial section 3D reconstruction of the PVN. Their results
suggest that, although CRF-producing neurons are mainly
situated along the 3V, as in the present study, AVP
expressing cells form a more complex wing-like region
within the nucleus. The present observations are more in
line with the previous work of Koutcherov et al. (2000),
who prepared a 3D immunohistochemistry-based human
PVN reconstruction in which CRF-immunostained cells
were most often localized nearer the 3V, while those im-
munostained for AVP typically extended more laterally.
However, we observed an appreciable overlap of cells
expressing each mRNA signal suggesting conjoint
Figure 14. Quantitative in situ hybridization for HDC, MCH, and orexin mRNA in the intermediate and caudal regions of the human hypothala-
mus. The suggested divisions are based in a combination of anatomical features and quantification of the signal intensity for each transcript.
A1–5: Subdivisions for HDC expression. (A1) Level of the caudal paraventricular nucleus. (A2) Level of the lateral tuberal nucleus. (A3) Pre-
mammillary level. (A4) Rostral mammillary level. (A5) Mammillary level. B1–4: MCH distribution can be divided in three main levels: (B1) pre-
mammillary level, (B2), rostral mammillary level and (B3), posterior hypothalamic level, with the higher intensity of signal at the second level.
C1–4: Suggested divisions for orexin signal: (C1) Periventricular level. (C2) Rostral premammillary level. (C3) Caudal premammillary level. (C4)
Rostral mammillary level. Asterisk denotes P < 0.05 versus ‘‘region one’’ within the rostrocaudal extent of analysis for each probe.
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transcription in a subpopulation of PVN neurons. This
may reflect increased sensitivity of the radiolabeled ISH
technique and/or posttranslational differences. It should
be noted that several previous immunocytochemical
investigations of the human PVN indicate that CRF and
AVP protein can be detected in the same PVN neurons
(Mouri et al., 1993). Other studies show that when com-
pared to controls, the PVNs in brains from depressed sub-
jects exhibit nearly a 3-fold increase in the number of
CRF neurons displaying coimmunoreactivity for AVP
(Raadsheer et al., 1994a). Enhanced colocalization of
CRF and AVP is also associated with aging and Alzhei-
mer’s disease (Raadsheer et al., 1994b,c). Thus, an
appreciable number of human periventricular localized
CRF neurons appear capable of acquiring a gain in AVP
transcription and this may be pertinent in the neurobiol-
ogy of depression. An analogous capacity may also exist
in rats, given that adrenalectomy or inhibition of axoplas-
mic transport with colchicine treatment increases CRF
and AVP colocalization in parvocellular neurons by about
2% and 70%, respectively (Sawchenko et al., 1984a). In a
surprising observation, we noted low CRF expression lev-
els in the human SON, seen only after saturation of the
radioactive labeling. This is unusual since local expres-
sion has not been described in the SON in other studies
of the human hypothalamus (Wang et al., 2008). In
rodents, however, it can be seen after physiological
manipulations, such as dehydration or salt loading (Imaki
et al., 1992; Kay-Nishiyama et al., 1999), which reveals
that these magnocellular neurons are capable of express-
ing the gene. Therefore, in our human brains, conditions
associated with the causes and nature of death may have
predisposed to the upregulation of CRF in the SON.
HDC, MCH, and ORX maps
Given the potential functional relationships of CRF and
AVP with other hypothalamic signaling molecules, we
sought to examine the mRNA expression pattern and
intensities of expression for HDC, MCH, and ORX. Expres-
sion of these transcripts overlapped to some extent, but
occurred in different nuclei along the rostrocaudal axis of
the human hypothalamus.
The distribution of HDC mRNA in the present study
agrees with the findings of the ISH-based study of Trottier
et al. (2002) as well as with the immunohistochemical
analysis of histaminergic neurons in human brain (Airaksi-
nen et al., 1991). The latter study localized histamine syn-
thesizing neurons in clusters collectively termed the
tuberomammillary complex. This complex was subdivided
into four distinct parts classified as medial (TMm), ventral
(TMv), caudal premammillary (TMc), and minor lateral
parts (TMl) (Airaksinan et al., 1991). In the present study,
maximum expression was found in the TMm, TMv, and
TMl but expressing cells were also found within the DM
and HLA.
The extent to which the present results relate to rodent
histamine neurochemistry is difficult to determine since the
rodent TM complex cannot be readily homologized to the
histaminergic E1–E5 cellular groups previously described in
rats (Castren and Panula, 1990; Airaksinan et al., 1991). The
distribution of histaminergic neurons in rodents is distin-
guished by more discrete cell clusters starting rostrally with
the E4–5 group located dorsal to the dorsomedial nucleus.
More caudally, the E2–3 group is positioned dorsal and lat-
eral to the arcuate nucleus, while the E1 group is present
only at the most posterior level of the mammillary nuclei
(Castren and Panula, 1990; Airaksinan et al., 1991). It will
be important to consider how the variations in human HDC
gene expression we observed might be related to HPA axis
activation in view of the increased expression of the immedi-
ate-early gene c-fos that occurs within E1–E5 histaminergic
neurons in rats exposed to stress (Miklos and Kovacs 2003).
Our examination of MCH and ORX mRNA expression
demonstrated patterns similar to those observed in previ-
ous immunohistochemical and ISH experiments on the
human hypothalamus (Elias et al., 1998, 2001; Thannickal
et al., 2007; Aziz et al., 2008). The anatomical localization
of these transcripts greatly overlapped in the DHA within
the anatomical planes of the premammillary area and ros-
tral mammillary region. Expression of the transcripts had
previously been localized to separate and distinct popula-
tions of neurons in both human and rat (Elias et al., 1998).
The analyses of MCH and ORX mRNA showed anatomical
heterogeneity, with mRNA signal reaching maximum inten-
sity for MCH mRNA in the DHA dorsal to the rostral mam-
millary bodies and for ORX mRNA in the DHA at the level
of the supramammillary region. These relationships differ
in human as compared to rat, since the most prominent
MCH expression in the rodent resides within the lateral
hypothalamic area and ORX expression is most abundant
within the dorsomedial and perifornical areas (Bittencourt
et al., 1992; Elias et al., 1998; Peyron et al., 1998; Nambu
et al., 1999). In the lateral hypothalamic area of the rat,
MCH and ORX have also been shown to be localized in dis-
crete populations of presympathetic motor neurons that
may regulate stress responses independent of ACTH
release (Kerman et al., 2007). Based on our findings as
well those of others, we suggest that the overlapping ana-
tomical pattern of MCH and ORX neurons in the human
potentially positions these neuropeptides to participate in
the regulation of similar biological processes.
CONCLUSION
The present anatomical study utilized classical histo-
logical techniques and ISH histochemistry in conjunction
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with computer-based mapping to generate 2D and 3D
reconstructions of the regions and nuclei containing CRF,
AVP, HDC, MCH, and ORX-expressing neurons in the
human hypothalamus. Through the use of these neuro-
chemical maps we were able to quantify the relative
mRNA signal strength in identical subregions across the
hypothalami of brains from different human subjects.
Although we did not find differences in CRF and AVP
expression at different rostrocaudal levels of the PVN,
significant anatomically dependant variations in the inten-
sity of HDC, MCH, and ORX were revealed. These data
further illustrate the neurochemical heterogeneity of the
human hypothalamus and will provide an anatomical tem-
plate for future quantitative experiments linking disease
and functional neuroanatomy.
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